核酸相似物:对其来源和分离过程的审查
Pan Wang1, Tao Cheng1, Jianming Pan1
1School of Chemistry and Chemical Engineering, Jiangsu University, Zhenjiang 212013, China.
Molecules (Basel, Switzerland)
|October 28, 2023
概括
本综述总结了核类同类的普遍分离方法,对于开发抗瘤和抗菌药物至关重要. 像分子印记这样的新技术提高了净化,改善了药物开发和疾病控制.
科学领域:
- 生物医学研究的研究.
- 化学合成 化学合成
- 药物开发 药物开发
背景情况:
- 核类类似物对于生产抗瘤和抗微生物药物至关重要.
- 目前的生产方法 (降解,合成,生物转化) 受到低产量,复杂矩阵和副产品的影响.
- 这些局限性阻碍了开发和研究新的核酸类比药物.
研究的目的:
- 审查核类同类的通用分离方法.
- 探索分子印记技术 (MIT) 在核酸类比分离中的应用.
- 为了比较分子印记聚合物 (MIP) 吸附剂用于核酸类比净化.
主要方法:
- 结晶化 结晶化 结晶化
- 高性能液体色谱 (HPLC) 是一种高性能液体色谱.
- 专色谱学 专色谱学 专色谱学
- 溶剂提取 提取 溶剂提取
- 吸附方式 吸附方式 吸附方式
- 分子印记技术 (MIT) 是一种分子印记技术.
主要成果:
- 现有的分离方法在产量和纯度方面存在挑战.
- 分子印记聚合物 (MIPs) 显示出核酸相似物选择性分离的前景.
- 改进的分离技术对于高效的核酸生产至关重要.
结论:
- 开发新的,选择性分离和核酸净化方法至关重要.
- 增强核类型的净化支持开发必要的抗瘤和抗病毒药物.
- 核分离的进步为环境,生物医学和临床应用提供了显著的好处.
更多相关视频
06:38Plant Sample Preparation for Nucleoside/Nucleotide Content Measurement with An HPLC-MS/MS
Published on: February 24, 2021
5.3K
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
8.7K
相关概念视频
01:28Biosynthesis of Nucleic Acids
56
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
56
01:14Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K